OPKO Health, Inc. (OPK)
NASDAQ: OPK · Real-Time Price · USD
1.240
-0.020 (-1.59%)
At close: May 9, 2025, 4:00 PM
1.260
+0.020 (1.61%)
After-hours: May 9, 2025, 7:54 PM EDT
OPKO Health Revenue
OPKO Health had revenue of $149.95M in the quarter ending March 31, 2025, a decrease of -13.66%. This brings the company's revenue in the last twelve months to $689.41M, down -13.78% year-over-year. In the year 2024, OPKO Health had annual revenue of $713.14M, down -17.41%.
Revenue (ttm)
$689.41M
Revenue Growth
-13.78%
P/S Ratio
1.23
Revenue / Employee
$230,033
Employees
2,997
Market Cap
983.39M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 713.14M | -150.35M | -17.41% |
Dec 31, 2023 | 863.50M | -140.70M | -14.01% |
Dec 31, 2022 | 1.00B | -770.52M | -43.42% |
Dec 31, 2021 | 1.77B | 339.31M | 23.64% |
Dec 31, 2020 | 1.44B | 533.48M | 59.15% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
OPK News
- 10 days ago - OPKO Health, Inc. (OPK) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - OPKO Health Announces $100 Million Increase to its Existing Share Repurchase Program - GlobeNewsWire
- 7 weeks ago - OPKO and Entera partner to develop obesity pill - Reuters
- 2 months ago - Labcorp Announces Acquisition of Select Assets of BioReference Health's Innovative Oncology and Related Clinical Testing Services Businesses - PRNewsWire
- 2 months ago - OPKO Health, Inc. (OPK) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - OPKO Health Reports Fourth Quarter 2024 Business Highlights and Financial Results - GlobeNewsWire
- 4 months ago - OPKO Health to Present at the 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 6 months ago - NextPlat to Showcase OPKO Healthcare Products at the 2024 China International Natural Health & Nutrition Expo - PRNewsWire